The agency's UK MD Kerrin Roberts strongly denied rumours of testing times for the agency.
But he confirmed that a number of individuals could be affected by the review.
‘Ten days ago I implemented a restructure to the Ogilvy PR UK business,' Roberts told PRWeek.
‘As part of rolling out that restructure, we have entered into a period of consultation with certain unnamed individuals. We have clients that we are working with and delivering results on.
‘We're out there taking part in many new business pitches,' he said. Roberts also would not confirm or deny rumours that several staff members were leaving the UK office. But it has also emerged that EMEA creative director Jim Dowling has left in the past few weeks.
Ogilvy EMEA CEO Martin Liptrot, who is based in London but has a regional remit, stressed that the restructure did not indicate a poor financial performance at the PR agency.
‘Ogilvy PR across Europe met and exceeded its 2007 budget numbers. We continually strive to innovate and differentiate our offer from others to service our clients in the most effective way,' said Liptrot.
The restructure is expected to end in a couple of weeks' time.
Ogilvy consolidated its healthcare offering at the end of last year. Ten healthcare employees were merged with Shire Health to create a new WPP division, OgilvyHealthPR.
This division will retain the structure of Shire Health by dividing its core offer of ‘business units' that include consumer health, pharma comms and pan-European comms.
Ogilvy PR UK is believed to employ 48 people. The restructure follows similar moves in France, Spain ad Ireland.
Liptrot confirmed three redundancies but would not give names.